Annual Non Current Assets
$76.06 B
+$2.17 B+2.94%
31 December 2023
Summary:
AstraZeneca annual long term assets is currently $76.06 billion, with the most recent change of +$2.17 billion (+2.94%) on 31 December 2023. During the last 3 years, it has risen by +$28.88 billion (+61.21%). AZN annual non current assets is now -3.86% below its all-time high of $79.12 billion, reached on 31 December 2021.AZN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$80.77 B
+$1.82 B+2.31%
30 September 2024
Summary:
AstraZeneca quarterly long term assets is currently $80.77 billion, with the most recent change of +$1.82 billion (+2.31%) on 30 September 2024. Over the past year, it has increased by +$7.18 billion (+9.76%). AZN quarterly non current assets is now at all-time high.AZN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | +9.8% |
| 3 y3 years | +61.2% | +0.3% |
| 5 y5 years | +68.8% | +78.0% |
AZN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -3.9% | +61.2% | at high | +9.8% |
| 5 y | 5 years | -3.9% | +68.8% | at high | +82.0% |
| alltime | all time | -3.9% | +3050.3% | at high | +3093.1% |
AstraZeneca Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $80.77 B(+2.3%) |
| June 2024 | - | $78.95 B(+2.9%) |
| Mar 2024 | - | $76.70 B(+0.8%) |
| Dec 2023 | $25.05 B(+10.9%) | $76.06 B(+3.4%) |
| Sept 2023 | - | $73.58 B(-0.2%) |
| June 2023 | - | $73.70 B(-1.0%) |
| Mar 2023 | - | $74.42 B(+0.7%) |
| Dec 2022 | $22.59 B(-13.9%) | $73.89 B(-0.1%) |
| Sept 2022 | - | $73.96 B(-2.2%) |
| June 2022 | - | $75.66 B(-2.5%) |
| Mar 2022 | - | $77.63 B(-1.9%) |
| Dec 2021 | $26.24 B(+34.3%) | $79.12 B(-1.8%) |
| Sept 2021 | - | $80.53 B(+73.7%) |
| June 2021 | - | $46.37 B(+0.4%) |
| Mar 2021 | - | $46.19 B(-2.1%) |
| Dec 2020 | $19.54 B(+25.6%) | $47.19 B(+2.7%) |
| Sept 2020 | - | $45.95 B(+2.1%) |
| June 2020 | - | $45.00 B(+1.4%) |
| Mar 2020 | - | $44.39 B(-3.1%) |
| Dec 2019 | $15.56 B(-0.2%) | $45.81 B(+0.9%) |
| Sept 2019 | - | $45.39 B(-2.8%) |
| June 2019 | - | $46.67 B(-1.6%) |
| Mar 2019 | - | $47.41 B(+5.2%) |
| Dec 2018 | $15.59 B(+18.6%) | $45.06 B(-6.8%) |
| Sept 2018 | - | $48.34 B(-1.1%) |
| June 2018 | - | $48.90 B(-2.4%) |
| Mar 2018 | - | $50.10 B(-0.2%) |
| Dec 2017 | $13.15 B(-0.8%) | $50.20 B(-1.5%) |
| Sept 2017 | - | $50.95 B(+0.3%) |
| June 2017 | - | $50.82 B(+3.0%) |
| Mar 2017 | - | $49.32 B(+0.1%) |
| Dec 2016 | $13.26 B(-17.1%) | $49.26 B(-2.2%) |
| Sept 2016 | - | $50.36 B(-1.5%) |
| June 2016 | - | $51.10 B(-0.9%) |
| Mar 2016 | - | $51.55 B(+17.0%) |
| Dec 2015 | $16.01 B(-4.1%) | $44.05 B(+7.6%) |
| Sept 2015 | - | $40.92 B(-1.1%) |
| June 2015 | - | $41.36 B(+0.8%) |
| Mar 2015 | - | $41.01 B(-2.1%) |
| Dec 2014 | $16.70 B(-17.9%) | $41.90 B(+2.0%) |
| Sept 2014 | - | $41.09 B(-2.9%) |
| June 2014 | - | $42.34 B(-1.2%) |
| Mar 2014 | - | $42.85 B(+20.5%) |
| Dec 2013 | $20.34 B(+6.8%) | $35.56 B(+0.7%) |
| Sept 2013 | - | $35.33 B(+2.1%) |
| June 2013 | - | $34.59 B(+1.8%) |
| Mar 2013 | - | $33.98 B(-1.5%) |
| Dec 2012 | $19.05 B(-19.0%) | $34.49 B(+0.2%) |
| Sept 2012 | - | $34.42 B(+8.9%) |
| June 2012 | - | $31.61 B(+8.3%) |
| Mar 2012 | - | $29.20 B(-0.4%) |
| Dec 2011 | $23.51 B(-6.5%) | $29.32 B(-2.6%) |
| Sept 2011 | - | $30.11 B(-2.0%) |
| June 2011 | - | $30.71 B(-1.1%) |
| Mar 2011 | - | $31.07 B(+0.2%) |
| Dec 2010 | $25.13 B | $31.00 B(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $31.82 B(+1.8%) |
| June 2010 | - | $31.27 B(-1.4%) |
| Mar 2010 | - | $31.73 B(+1.8%) |
| Dec 2009 | $23.76 B(+49.7%) | $31.16 B(-0.6%) |
| Sept 2009 | - | $31.36 B(+0.9%) |
| June 2009 | - | $31.07 B(+1.3%) |
| Mar 2009 | - | $30.66 B(-1.3%) |
| Dec 2008 | $15.87 B(-7.1%) | $31.08 B(-4.8%) |
| Sept 2008 | - | $32.63 B(-3.2%) |
| June 2008 | - | $33.73 B(-0.8%) |
| Mar 2008 | - | $34.01 B(+10.1%) |
| Dec 2007 | $17.08 B(+0.9%) | $30.88 B(-1.2%) |
| Sept 2007 | - | $31.26 B(-0.8%) |
| June 2007 | - | $31.52 B(+137.4%) |
| Mar 2007 | - | $13.28 B(+2.2%) |
| Dec 2006 | $16.94 B(+23.0%) | $13.00 B(-5.1%) |
| Sept 2006 | - | $13.69 B(+2.1%) |
| June 2006 | - | $13.41 B(+3.2%) |
| Mar 2006 | - | $13.00 B(+17.4%) |
| Dec 2005 | $13.77 B(+5.7%) | $11.07 B(-3.2%) |
| Sept 2005 | - | $11.43 B(-0.1%) |
| June 2005 | - | $11.45 B(+3.4%) |
| Mar 2005 | - | $11.07 B(-12.3%) |
| Dec 2004 | $13.03 B(+0.7%) | $12.63 B(+3.3%) |
| Sept 2004 | - | $12.22 B(-1.7%) |
| June 2004 | - | $12.43 B(+18.1%) |
| Mar 2004 | - | $10.52 B(-1.1%) |
| Dec 2003 | $12.93 B(+6.7%) | $10.64 B(+5.8%) |
| Sept 2003 | - | $10.06 B(+1.2%) |
| June 2003 | - | $9.94 B(+3.8%) |
| Mar 2003 | - | $9.58 B(+1.4%) |
| Dec 2002 | $12.13 B(+17.0%) | $9.45 B(+5.0%) |
| Sept 2002 | - | $9.00 B(+1.2%) |
| June 2002 | - | $8.90 B(+8.3%) |
| Mar 2002 | - | $8.22 B(+1.1%) |
| Dec 2001 | $10.36 B(-1.5%) | $8.13 B(+2.4%) |
| Sept 2001 | - | $7.95 B(+3.7%) |
| June 2001 | - | $7.66 B(+0.4%) |
| Mar 2001 | - | $7.63 B(-3.8%) |
| Dec 2000 | $10.52 B(+6.1%) | $7.93 B(-14.5%) |
| Sept 2000 | - | $9.26 B(-4.6%) |
| June 2000 | - | $9.71 B(+22.7%) |
| Mar 2000 | - | $7.91 B(-20.1%) |
| Dec 1999 | $9.91 B(+5.4%) | $9.90 B(-2.1%) |
| Sept 1999 | - | $10.12 B(+2.5%) |
| June 1999 | - | $9.87 B(+8.8%) |
| Dec 1998 | $9.40 B(+99.2%) | $9.07 B(+115.9%) |
| June 1998 | - | $4.20 B(+18.0%) |
| Dec 1997 | $4.72 B(-9.2%) | $3.56 B(+5.8%) |
| Dec 1996 | $5.20 B(+6.8%) | $3.37 B(+12.0%) |
| Dec 1995 | $4.86 B(+7.0%) | $3.01 B(+0.7%) |
| June 1995 | - | $2.98 B(+7.7%) |
| Dec 1994 | $4.55 B(-7.1%) | $2.77 B(+9.5%) |
| Dec 1993 | $4.89 B(+29.7%) | $2.53 B |
| Dec 1992 | $3.77 B(+0.1%) | - |
| Dec 1991 | $3.77 B(+6.3%) | - |
| Dec 1990 | $3.55 B | - |
FAQ
- What is AstraZeneca annual long term assets?
- What is the all time high annual non current assets for AstraZeneca?
- What is AstraZeneca annual non current assets year-on-year change?
- What is AstraZeneca quarterly long term assets?
- What is the all time high quarterly non current assets for AstraZeneca?
- What is AstraZeneca quarterly non current assets year-on-year change?
What is AstraZeneca annual long term assets?
The current annual non current assets of AZN is $76.06 B
What is the all time high annual non current assets for AstraZeneca?
AstraZeneca all-time high annual long term assets is $79.12 B
What is AstraZeneca annual non current assets year-on-year change?
Over the past year, AZN annual long term assets has changed by +$2.17 B (+2.94%)
What is AstraZeneca quarterly long term assets?
The current quarterly non current assets of AZN is $80.77 B
What is the all time high quarterly non current assets for AstraZeneca?
AstraZeneca all-time high quarterly long term assets is $80.77 B
What is AstraZeneca quarterly non current assets year-on-year change?
Over the past year, AZN quarterly long term assets has changed by +$7.18 B (+9.76%)